首页> 外文期刊>Acta Medica Academica >Tissue necrosis following extravasation of acyclovir in an adolescent: A case report
【24h】

Tissue necrosis following extravasation of acyclovir in an adolescent: A case report

机译:青少年使用阿昔洛韦外渗后组织坏死:一例报告

获取原文
           

摘要

Objective. Extravasation of intravenously infused vesicant solutions is a common problem in medical practice, which can lead to severe and progressive tissue dysfunction, ranging from persistent tissue oedema and fibrosis to delayed tissue necrosis. Acyclovir is a known vesicant medication administrated in paediatric patients, which appears to irritate venous and soft tissue if extravasated. Case report. We present the first case involving the extravasation of intravenously infused acyclovir in a female adolescent patient, which caused tissue necrosis and left behind a residual scar lesion. Nursing and medical staff should be aware of the potential dermatological side effects of intravenously infused acyclovir and other medications, even a long time after infusion, and the possible lack of initial local symptoms and signs. Conclusion. Early recognition of extravasation and prompt management are critical in preventing further morbidity, and optimizing outcomes.
机译:目的。静脉内注入的泡沫剂溶液的渗出是医学实践中的常见问题,其可导致严重的和进行性的组织功能障碍,范围从持续的组织水肿和纤维化到延迟的组织坏死。阿昔洛韦是一种在儿科患者中使用的已知的止痛药,如果渗出过多,似乎会刺激静脉和软组织。案例报告。我们提出了第一例,涉及一名女性青少年患者静脉注射阿昔洛韦的渗出,这导致组织坏死并留下残留的疤痕病变。护理和医务人员应注意静脉输注阿昔洛韦和其他药物的潜在皮肤病学副作用,即使输注后很长一段时间,也可能缺乏最初的局部症状和体征。结论。尽早发现外渗并及时处理对于预防进一步发病和优化结果至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号